Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.
Press releases published on April 29, 2025
From Fear to Love 2025: Bryan Post Brings Trauma-Informed Parenting Workshop to Tulsa
EIN Presswire
·
April 29, 2025
TULSA, OK, UNITED STATES, April 29, 2025 /EINPresswire.com/ -- Tulsa, OK will welcome nationally recognized child behavior expert Bryan Post on May 2, 2025, as part of the From Fear to Love 2025 World Tour. This live, in-person event brings Bryan’s …
Stand For Silent is Building a Brighter Future: Scholarships and Resources for Bullying Prevention
EIN Presswire
·
April 29, 2025
Stand for the Silent is Investing in Tomorrow's Leaders Through Education and Support. OKLAHOMA CITY, OK, UNITED STATES, April 29, 2025 /EINPresswire.com/ -- There are students around the country who are working toward preventing bullying, but they …
NASP Message to Congress: You Must Do More to Protect Safe Senior Access to Specialty Medications and Medication Services and Protect Pharmacy Market Competition
GlobeNewswire
·
April 29, 2025
Washington, DC, April 29, 2025 (GLOBE NEWSWIRE) -- Today, the full House Committee on Energy and Commerce passed H.R. 2484, legislation that is intended to improve the convenience of accessing Medicare Part D drugs for patients and their caregivers, but …
National Service Office to Host Denver Screening of New Documentary "American Delivery"
GlobeNewswire
·
April 29, 2025
DENVER, COLO., April 29, 2025 (GLOBE NEWSWIRE) -- The National Service Office for Nurse-Family Partnership ® and Child First invites community members, supporters, and partners to a special in-person screening event of American Delivery—a powerful new …
iTeos meldet Finanzergebnisse für das erste Quartal 2025 und gibt aktuelle Geschäftsinformationen bekannt
GlobeNewswire
·
April 29, 2025
- Topline-Zwischenergebnisse von GALAXIES Lung-201 mit >240 Patienten im 2. Quartal 2025 erwartet - Zwischenergebnisse von GALAXIES H…
iTeos publie les résultats financiers de son premier trimestre 2025 et fait le point sur ses activités
GlobeNewswire
·
April 29, 2025
- Données de haut niveau provisoires issues de l’essai GALAXIES Lung-201, et plus de 240 patients attendus au deuxième trimestre 2025 - Données provisoires issues des essais GALAXIES H…
Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
GlobeNewswire
·
April 29, 2025
FREMONT, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Continuing its commitment to advancing cell analysis, Cytek Biosciences, Inc. (Nasdaq: CTKB) is showcasing its patented Full Spectrum Profiling™ (FSP®) technology at CYTO 2025 and American Association of …
Nuo Therapeutics Announces Exclusive Private Label Distribution Agreement with Smith+Nephew
GlobeNewswire
·
April 29, 2025
HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on emerging opportunities in the evolving healthcare landscape, …
Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR Meeting
GlobeNewswire
·
April 29, 2025
Phase 1a dose-escalation study data update: treatment with NXP900 resulted in exposure levels leading to robust pharmacodynamic responses across a range of tolerated doses; NXP900 has an acceptable safety profile, dose limiting toxicity dose level has not …
CooperCompanies Announces Release Date for Second Quarter 2025
GlobeNewswire
·
April 29, 2025
SAN RAMON, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report second quarter 2025 financial results on Thursday, May 29, 2025, at 4:15 PM ET. Following the release, …
Certara to Participate in Upcoming Investor Conferences
GlobeNewswire
·
April 29, 2025
RADNOR, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences: BofA Securities 2025 …
Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire
·
April 29, 2025
-- Nasdaq Compliance Follows ADS Ratio Change to Secure Company’s Public Listing -- -- Amarin Remains Focused on Maximizing the Global Value of VASCEPA/VAZKEPA – DUBLIN and BRIDGEWATER, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc ( …
The Ensign Group Reports First Quarter 2025 Results; Raises Annual Earnings and Revenue Guidance
GlobeNewswire
·
April 29, 2025
SAN JUAN CAPISTRANO, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign(TM) group of companies, which provide post-acute healthcare services and invest in the long-term healthcare industry, …
Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis
GlobeNewswire
·
April 29, 2025
Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis The Phase 3 ABTECT trials (Studies 105 and 106) evaluating obefazimod in patients with moderately to severely active …
Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time
GlobeNewswire
·
April 29, 2025
GERMANTOWN, Md., April 29, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people …
Erasca Presents New Preclinical Data Reinforcing Best-in-Class Potential of RAS-Targeting Franchise at the 2025 AACR Annual Meeting
GlobeNewswire
·
April 29, 2025
ERAS-0015 and ERAS-4001 showed robust anti-tumor activity as monotherapy and combination therapy First-in-class examples of direct SHOC2 binders and modulators of SMP complex assembly identified with potential to block oncogenic RAS/MAPK pathway signaling …
PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June
GlobeNewswire
·
April 29, 2025
SAN JOSE, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today that members of …
BridgeBio Reports First Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
April 29, 2025
- $36.7 million in first full quarter of U.S. Attruby™ net product revenue and as of April 25, 2025, 2,072 unique patient prescriptions written by 756 unique prescribers - Observational run-in study for hypochondroplasia Phase 2 trial fully enrolled …
BeautyHealth to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire
·
April 29, 2025
LONG BEACH, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report first quarter 2025 financial results after market close on Thursday, May 8, 2025. The …
Artios Pharma Reports Differentiated Clinical Activity in STELLA Phase 1/2a Study for Lead Program ART0380 at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewswire
·
April 29, 2025
ART0380 in combination with low-dose irinotecan demonstrated a 50% confirmed overall response rate (cORR) in patients with Ataxia-Telangiectasia Mutated (ATM)-negative1 solid tumors at the recommended Phase 2 dose (RP2D) 37% cORR observed in patients with …